نتائج البحث - "DENDRITIC CELL-DEVELOPMENT"

العلاقة: Giza, Heather M.; Bozzacco, Leonia (2021). "Unboxing dendritic cells: Tales of multi‐faceted biology and function." Immunology (3): 433-449.; https://hdl.handle.net/2027.42/170887Test; Immunology; van de Pavert SA, Olivier BJ, Goverse G, Vondenhoff MF, Greuter M, Beke P, et al. Chemokine CXCL13 is essential for lymph node initiation and is induced by retinoic acid and neuronal stimulation. Nat Immunol. 2009; 10: 1193 – 9.; Ouabed A, Hubert FX, Chabannes D, Gautreau L, Heslan M, Josien R. Differential control of T regulatory cell proliferation and suppressive activity by mature plasmacytoid versus conventional spleen dendritic cells. J Immunol. 2008; 180: 5862 – 70.; Flacher V, Tripp CH, Mairhofer DG, Steinman RM, Stoitzner P, Idoyaga J, et al. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross‐tolerance. EMBO Mol Med. 2014; 6: 1191 – 204.; Strandt H, Pinheiro DF, Kaplan DH, Wirth D, Gratz IK, Hammerl P, et al. Neoantigen expression in steady‐state langerhans cells induces CTL tolerance. J Immunol. 2017; 199: 1626 – 34.; Seneschal J, Clark RA, Gehad A, Baecher‐Allan CM, Kupper TS. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity. 2012; 36: 873 – 84.; Trumpfheller C, Longhi MP, Caskey M, Idoyaga J, Bozzacco L, Keler T, et al. Dendritic cell‐targeted protein vaccines: a novel approach to induce T‐cell immunity. J Intern Med. 2012; 271: 183 – 92.; Dhodapkar MV, Sznol M, Zhao B, Wang D, Carvajal RD, Keohan ML, et al. Induction of antigen‐specific immunity with a vaccine targeting NY‐ESO‐1 to the dendritic cell receptor DEC‐205. Sci Transl Med. 2014; 6: 232ra51.; Bhardwaj N, Friedlander PA, Pavlick AC, Ernstoff MS, Gastman BR, Hanks BA, et al. Flt3 ligand augments immune responses to anti‐DEC‐205‐NY‐ESO‐1 vaccine through expansion of dendritic cell subsets. Nature Cancer. 2020; 1: 1204 – 17.; Sirvent S, Soria I, Cirauqui C, Cases B, Manzano AI, Diez‐Rivero CM, et al. Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory T cells through programmed death ligand 1. J Allergy Clin Immunol. 2016; 138: 558 – 67.e11.; Fossum E, Tesfaye DY, Bobic S, Gudjonsson A, Braathen R, Lahoud MH, et al. Targeting antigens to different receptors on conventional type 1 dendritic cells impacts the immune response. J Immunol. 2020; 205: 661 – 73.; Oba T, Long MD, Keler T, Marsh HC, Minderman H, Abrams SI, et al. Overcoming primary and acquired resistance to anti‐PD‐L1 therapy by induction and activation of tumor‐residing cDC1s. Nat Commun. 2020; 11: 5415.; Joffre OP, Sancho D, Zelenay S, Keller AM, Reis e Sousa C. Efficient and versatile manipulation of the peripheral CD4+ T‐cell compartment by antigen targeting to DNGR‐1/CLEC9A. Eur J Immunol. 2010; 40: 1255 – 65.; Kato Y, Steiner TM, Park HY, Hitchcock RO, Zaid A, Hor JL, et al. Display of native antigen on cDC1 that have spatial access to both T and B cells underlies efficient humoral vaccination. J Immunol. 2020; 205: 1842 – 56.; Gudjonsson A, Lysen A, Balan S, Sundvold‐Gjerstad V, Arnold‐Schrauf C, Richter L, et al. Targeting influenza virus hemagglutinin to Xcr1(+) dendritic cells in the absence of receptor‐mediated endocytosis enhances protective antibody responses. J Immunol. 2017; 198: 2785 – 95.; Gudjonsson A, Andersen TK, Sundvold‐Gjerstad V, Bogen B, Fossum E. Endocytosis deficient murine Xcl1‐fusion vaccine enhances protective antibody responses in mice. Front Immunol. 2019; 10: 1086.; Fossum E, Grodeland G, Terhorst D, Tveita AA, Vikse E, Mjaaland S, et al. Vaccine molecules targeting Xcr1 on cross‐presenting DCs induce protective CD8+ T‐cell responses against influenza virus. Eur J Immunol. 2015; 45: 624 – 35.; Hartung E, Becker M, Bachem A, Reeg N, Jakel A, Hutloff A, et al. Induction of potent CD8 T cell cytotoxicity by specific targeting of antigen to cross‐presenting dendritic cells in vivo via murine or human XCR1. J Immunol. 2015; 194: 1069 – 79.; Chappell CP, Giltiay NV, Draves KE, Chen C, Hayden‐Ledbetter MS, Shlomchik MJ, et al. Targeting antigens through blood dendritic cell antigen 2 on plasmacytoid dendritic cells promotes immunologic tolerance. J Immunol. 2014; 192: 5789 – 801.; Panda SK, Kolbeck R, Sanjuan MA. Plasmacytoid dendritic cells in autoimmunity. Curr Opin Immunol. 2017; 44: 20 – 5.; Kranich J, Krautler NJ, Heinen E, Polymenidou M, Bridel C, Schildknecht A, et al. Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J Exp Med. 2008; 205: 1293 – 302.; Rahman ZS, Shao WH, Khan TN, Zhen Y, Cohen PL. Impaired apoptotic cell clearance in the germinal center by Mer‐deficient tingible body macrophages leads to enhanced antibody‐forming cell and germinal center responses. J Immunol. 2010; 185: 5859 – 68.; Suurmond J, Diamond B. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest. 2015; 125: 2194 – 202.; Kim JH, Hu Y, Yongqing T, Kim J, Hughes VA, Le Nours J, et al. CD1a on Langerhans cells controls inflammatory skin disease. Nat Immunol. 2016; 17: 1159 – 66.; Bofill M, Akbar AN, Amlot PL. Follicular dendritic cells share a membrane‐bound protein with fibroblasts. J Pathol. 2000; 191: 217 – 26.; Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med. 1973; 137: 1142 – 62.; van Spriel AB, de Jong EC. Dendritic cell science: more than 40 years of history. J Leukoc Biol. 2013; 93: 33 – 8.; Miller JJ 3rd, Nossal GJ. Antigens in immunity. Vi. The phagocytic reticulum of lymph node follicles. J Exp Med. 1964; 120: 1075 – 86.; Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony‐stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994; 179: 1109 – 18.; Prodinger C, Bunse J, Kruger M, Schiefenhovel F, Brandt C, Laman JD, et al. CD11c‐expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 2011; 121: 445 – 58.; Alcantara‐Hernandez M, Leylek R, Wagar LE, Engleman EG, Keler T, Marinkovich MP, et al. High‐dimensional phenotypic mapping of human dendritic cells reveals interindividual variation and tissue specialization. Immunity. 2017; 47: 1037 – 50.e6.; Asselin‐Paturel C, Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med. 2005; 202: 461 – 5.; See P, Dutertre CA, Chen J, Günther P, McGovern N, Irac SE, et al. Mapping the human DC lineage through the integration of high‐dimensional techniques. Science (New York, N.Y.). 2017; 356: eaag3009. https://doi.org/10.1126/science.aag3009Test; Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single‐cell RNA‐seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017; 356.; Traver D, Akashi K, Manz M, Merad M, Miyamoto T, Engleman EG, et al. Development of CD8alpha‐positive dendritic cells from a common myeloid progenitor. Science. 2000; 290: 2152 – 4.; Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood. 2001; 97: 3333 – 41.; Chicha L, Jarrossay D, Manz MG. Clonal type I interferon‐producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J Exp Med. 2004; 200: 1519 – 24.; Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR, et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science. 2006; 311: 83 – 7.; Shigematsu H, Reizis B, Iwasaki H, Mizuno S, Hu D, Traver D, et al. Plasmacytoid dendritic cells activate lymphoid‐specific genetic programs irrespective of their cellular origin. Immunity. 2004; 21: 43 – 53.; Corcoran L, Ferrero I, Vremec D, Lucas K, Waithman J, O’Keeffe M, et al. The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. J Immunol. 2003; 170: 4926 – 32.; Pelayo R, Welner R, Perry SS, Huang J, Baba Y, Yokota T, et al. Lymphoid progenitors and primary routes to becoming cells of the immune system. Curr Opin Immunol. 2005; 17: 100 – 7.; Dress RJ, Dutertre CA, Giladi A, Schlitzer A, Low I, Shadan NB, et al. Plasmacytoid dendritic cells develop from Ly6D(+) lymphoid progenitors distinct from the myeloid lineage. Nat Immunol. 2019; 20: 852 – 64.; Rodrigues PF, Alberti‐Servera L, Eremin A, Grajales‐Reyes GE, Ivanek R, Tussiwand R. Distinct progenitor lineages contribute to the heterogeneity of plasmacytoid dendritic cells. Nat Immunol. 2018; 19: 711 – 22.; Hoeffel G, Wang Y, Greter M, See P, Teo P, Malleret B, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac‐derived macrophages. J Exp Med. 2012; 209: 1167 – 81.; Schulz C, Gomez Perdiguero E, Chorro L, Szabo‐Rogers H, Cagnard N, Kierdorf K, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012; 336: 86 – 90.; Lindhout E, van Eijk M, van Pel M, Lindeman J, Dinant HJ, de Groot C. Fibroblast‐like synoviocytes from rheumatoid arthritis patients have intrinsic properties of follicular dendritic cells. J Immunol. 1999; 162: 5949 – 56.; Munoz‐Fernandez R, Blanco FJ, Frecha C, Martin F, Kimatrai M, Abadia‐Molina AC, et al. Follicular dendritic cells are related to bone marrow stromal cell progenitors and to myofibroblasts. J Immunol. 2006; 177: 280 – 9.; Aguzzi A, Kranich J, Krautler NJ. Follicular dendritic cells: origin, phenotype, and function in health and disease. Trends Immunol. 2014; 35: 105 – 13.; Naik SH, Proietto AI, Wilson NS, Dakic A, Schnorrer P, Fuchsberger M, et al. Cutting edge: generation of splenic CD8+ and CD8‐ dendritic cell equivalents in Fms‐like tyrosine kinase 3 ligand bone marrow cultures. J Immunol. 2005; 174: 6592 – 7.; Waskow C, Liu K, Darrasse‐Jeze G, Guermonprez P, Ginhoux F, Merad M, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol. 2008; 9: 676 – 83.; Merad M, Manz MG. Dendritic cell homeostasis. Blood. 2009; 113: 3418 – 27.; Chorro L, Sarde A, Li M, Woollard KJ, Chambon P, Malissen B, et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation‐associated expansion of the epidermal LC network. J Exp Med. 2009; 206: 3089 – 100.; Onai N, Obata‐Onai A, Tussiwand R, Lanzavecchia A, Manz MG. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon‐producing and dendritic cell development. J Exp Med. 2006; 203: 227 – 38.; Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand‐treated mice: multiple dendritic cell subpopulations identified. J Exp Med. 1996; 184: 1953 – 62.; Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, Hoek J, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood. 2000; 96: 878 – 84.; Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX‐301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015; 50: 924 – 30.; Vremec D, Lieschke GJ, Dunn AR, Robb L, Metcalf D, Shortman K. The influence of granulocyte/macrophage colony‐stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur J Immunol. 1997; 27: 40 – 4.; Kingston D, Schmid MA, Onai N, Obata‐Onai A, Baumjohann D, Manz MG. The concerted action of GM‐CSF and Flt3‐ligand on in vivo dendritic cell homeostasis. Blood. 2009; 114: 835 – 43.; Bogunovic M, Ginhoux F, Helft J, Shang L, Hashimoto D, Greter M, et al. Origin of the lamina propria dendritic cell network. Immunity. 2009; 31: 513 – 25.; King IL, Kroenke MA, Segal BM. GM‐CSF‐dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization. J Exp Med. 2010; 207: 953 – 61.; Zhan Y, Lieschke GJ, Grail D, Dunn AR, Cheers C. Essential roles for granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) and G‐CSF in the sustained hematopoietic response of Listeria monocytogenes‐infected mice. Blood. 1998; 91: 863 – 9.; Hume DA, Pavli P, Donahue RE, Fidler IJ. The effect of human recombinant macrophage colony‐stimulating factor (CSF‐1) on the murine mononuclear phagocyte system in vivo. J Immunol. 1988; 141: 3405 – 9.; Onai N, Obata‐Onai A, Schmid MA, Ohteki T, Jarrossay D, Manz MG. Identification of clonogenic common Flt3+M‐CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol. 2007; 8: 1207 – 16.; Fancke B, Suter M, Hochrein H, O’Keeffe M. M‐CSF: a novel plasmacytoid and conventional dendritic cell poietin. Blood. 2008; 111: 150 – 9.; Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M, et al. IL‐34 is a tissue‐restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol. 2012; 13: 753 – 60.; Lee J, Breton G, Aljoufi A, Zhou YJ, Puhr S, Nussenzweig MC, et al. Clonal analysis of human dendritic cell progenitor using a stromal cell culture. J Immunol Methods. 2015; 425: 21 – 6.; Lee J, Breton G, Oliveira TY, Zhou YJ, Aljoufi A, Puhr S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015; 212: 385 – 99.; Breton G, Lee J, Zhou YJ, Schreiber JJ, Keler T, Puhr S, et al. Circulating precursors of human CD1c+ and CD141+ dendritic cells. J Exp Med. 2015; 212: 401 – 13.; Manz MG, Miyamoto T, Akashi K, Weissman IL. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA. 2002; 99: 11872 – 7.; Haniffa M, Collin M, Ginhoux F. Ontogeny and functional specialization of dendritic cells in human and mouse. Adv Immunol. 2013; 120: 1 – 49.; Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol. 2013; 31: 563 – 604.; Murphy TL, Grajales‐Reyes GE, Wu X, Tussiwand R, Briseno CG, Iwata A, et al. Transcriptional control of dendritic cell development. Annu Rev Immunol. 2016; 34: 93 – 119.; Rathinam C, Geffers R, Yucel R, Buer J, Welte K, Moroy T, et al. The transcriptional repressor Gfi1 controls STAT3‐dependent dendritic cell development and function. Immunity. 2005; 22: 717 – 28.; Kueh HY, Champhekar A, Nutt SL, Elowitz MB, Rothenberg EV. Positive feedback between PU.1 and the cell cycle controls myeloid differentiation. Science. 2013; 341: 670 – 3.; Carotta S, Dakic A, D’Amico A, Pang SH, Greig KT, Nutt SL, et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose‐dependent manner. Immunity. 2010; 32: 628 – 41.; Cisse B, Caton ML, Lehner M, Maeda T, Scheu S, Locksley R, et al. Transcription factor E2–2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell. 2008; 135: 37 – 48.; Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH. Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre‐DC)2 but not into pre‐DC1. Evidence for a lymphoid origin of pre‐DC2. J Exp Med. 2000; 192: 1775 – 84.; Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse HC 3rd, et al. ICSBP is essential for the development of mouse type I interferon‐producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med. 2002; 196: 1415 – 25.; Schiavoni G, Mattei F, Borghi P, Sestili P, Venditti M, Morse HC 3rd, et al. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood. 2004; 103: 2221 – 8.; Cytlak U, Resteu A, Pagan S, Green K, Milne P, Maisuria S, et al. Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans. Immunity. 2020; 53: 353 – 70.e8.; Vander Lugt B, Khan AA, Hackney JA, Agrawal S, Lesch J, Zhou M, et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol. 2014; 15: 161 – 7.; Fong L, Hou Y, Rivas A, Benike C, Yuen A, Fisher GA, et al. Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc Natl Acad Sci USA. 2001; 98: 8809 – 14.; Suzuki S, Honma K, Matsuyama T, Suzuki K, Toriyama K, Akitoyo I, et al. Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha‐ dendritic cell development. Proc Natl Acad Sci USA. 2004; 101: 8981 – 6.; Esashi E, Wang YH, Perng O, Qin XF, Liu YJ, Watowich SS. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity. 2008; 28: 509 – 20.; Satpathy AT, Briseno CG, Lee JS, Ng D, Manieri NA, Kc W, et al. Notch2‐dependent classical dendritic cells orchestrate intestinal immunity to attaching‐and‐effacing bacterial pathogens. Nat Immunol. 2013; 14: 937 – 48.; Grajales‐Reyes GE, Iwata A, Albring J, Wu X, Tussiwand R, Kc W, et al. Batf3 maintains autoactivation of Irf8 for commitment of a CD8alpha(+) conventional DC clonogenic progenitor. Nat Immunol. 2015; 16: 708 – 17.; Schlitzer A, Sivakamasundari V, Chen J, Sumatoh HR, Schreuder J, Lum J, et al. Identification of cDC1‐ and cDC2‐committed DC progenitors reveals early lineage priming at the common DC progenitor stage in the bone marrow. Nat Immunol. 2015; 16: 718 – 28.; Tussiwand R, Everts B, Grajales‐Reyes GE, Kretzer NM, Iwata A, Bagaitkar J, et al. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity. 2015; 42: 916 – 28.; Bagadia P, Huang X, Liu TT, Durai V, Grajales‐Reyes GE, Nitschke M, et al. An Nfil3‐Zeb2‐Id2 pathway imposes Irf8 enhancer switching during cDC1 development. Nat Immunol. 2019; 20: 1174 – 85.; Bajana S, Turner S, Paul J, Ainsua‐Enrich E, Kovats S. IRF4 and IRF8 act in CD11c+ cells to regulate terminal differentiation of lung tissue dendritic cells. J Immunol. 2016; 196: 1666 – 77.; Hashimoto D, Miller J, Merad M. Dendritic cell and macrophage heterogeneity in vivo. Immunity. 2011; 35: 323 – 35.; Edelson BT, Bradstreet TR, Kc W, Hildner K, Herzog JW, Sim J, et al. Batf3‐dependent CD11b(low/‐) peripheral dendritic cells are GM‐CSF‐independent and are not required for Th cell priming after subcutaneous immunization. PLoS One. 2011; 6: e25660.; Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science. 2008; 322: 1097 – 100.; Tussiwand R, Lee WL, Murphy TL, Mashayekhi M, Kc W, Albring JC, et al. Compensatory dendritic cell development mediated by BATF‐IRF interactions. Nature. 2012; 490: 502 – 7.; Dickinson RE, Griffin H, Bigley V, Reynard LN, Hussain R, Haniffa M, et al. Exome sequencing identifies GATA‐2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood. 2011; 118: 2656 – 8.; Hambleton S, Salem S, Bustamante J, Bigley V, Boisson‐Dupuis S, Azevedo J, et al. IRF8 mutations and human dendritic‐cell immunodeficiency. N Engl J Med. 2011; 365: 127 – 38.; Guilliams M, Dutertre CA, Scott CL, McGovern N, Sichien D, Chakarov S, et al. Unsupervised high‐dimensional analysis aligns dendritic cells across tissues and species. Immunity. 2016; 45: 669 – 84.; van der Aa E, van Montfoort N, Woltman AM. BDCA3(+)CLEC9A(+) human dendritic cell function and development. Semin Cell Dev Biol. 2015; 41: 39 – 48.; Vremec D, Zorbas M, Scollay R, Saunders DJ, Ardavin CF, Wu L, et al. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J Exp Med. 1992; 176: 47 – 58.; Annacker O, Coombes JL, Malmstrom V, Uhlig HH, Bourne T, Johansson‐Lindbom B, et al. Essential role for CD103 in the T cell‐mediated regulation of experimental colitis. J Exp Med. 2005; 202: 1051 – 61.; Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, et al. Human tissues contain CD141hi cross‐presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity. 2012; 37: 60 – 73.; McKenzie EJ, Taylor PR, Stillion RJ, Lucas AD, Harris J, Gordon S, et al. Mannose receptor expression and function define a new population of murine dendritic cells. J Immunol. 2007; 178: 4975 – 83.; Segura E, Valladeau‐Guilemond J, Donnadieu MH, Sastre‐Garau X, Soumelis V, Amigorena S. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med. 2012; 209: 653 – 60.; Dutertre CA, Becht E, Irac SE, Khalilnezhad A, Narang V, Khalilnezhad S, et al. Single‐Cell analysis of human mononuclear phagocytes reveals subset‐defining markers and identifies circulating inflammatory dendritic cells. Immunity. 2019; 51: 573 – 89.e8.; Bourdely P, Anselmi G, Vaivode K, Ramos RN, Missolo‐Koussou Y, Hidalgo S, et al. Transcriptional and functional analysis of CD1c(+) human dendritic cells identifies a CD163(+) subset priming CD8(+)CD103(+) T cells. Immunity. 2020; 53: 335 – 52.e8.; Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN‐producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol. 2006; 177: 3260 – 5.; Liu K, Victora GD, Schwickert TA, Guermonprez P, Meredith MM, Yao K, et al. In vivo analysis of dendritic cell development and homeostasis. Science. 2009; 324: 392 – 7.; Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, et al. Quantitative expression of toll‐like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002; 168: 4531 – 7.; Leylek R, Alcantara‐Hernandez M, Lanzar Z, Ludtke A, Perez OA, Reizis B, et al. Integrated cross‐species analysis identifies a conserved transitional dendritic cell population. Cell Rep. 2019; 29: 3736 – 50.e8.; Abbas A, Vu Manh TP, Valente M, Collinet N, Attaf N, Dong C, et al. The activation trajectory of plasmacytoid dendritic cells in vivo during a viral infection. Nat Immunol. 2020; 21: 983 – 97.; Coillard A, Segura E. In vivo differentiation of human monocytes. Front Immunol. 2019; 10: 1907.; Sprangers S, de Vries TJ, Everts V. Monocyte heterogeneity: consequences for monocyte‐derived immune cells. J Immunol Res. 2016; 2016: 1475435.; Wang X, Cho B, Suzuki K, Xu Y, Green JA, An J, et al. Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J Exp Med. 2011; 208: 2497 – 510.; Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, Geuze HJ. Follicular dendritic cells carry MHC class II‐expressing microvesicles at their surface. J Immunol. 2000; 165: 1259 – 65.; McCloskey ML, Curotto de Lafaille MA, Carroll MC, Erlebacher A. Acquisition and presentation of follicular dendritic cell‐bound antigen by lymph node‐resident dendritic cells. J Exp Med. 2011; 208: 135 – 48.; El Shikh ME, Pitzalis C. Follicular dendritic cells in health and disease. Front Immunol. 2012; 3: 292.; Tew JG, Wu J, Fakher M, Szakal AK, Qin D. Follicular dendritic cells: beyond the necessity of T‐cell help. Trends Immunol. 2001; 22: 361 – 7.; Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol. 2009; 9: 618 – 29.; Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, Lemm D, et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell. 2012; 150: 194 – 206.; Merad M, Ginhoux F, Collin M. Origin, homeostasis and function of Langerhans cells and other langerin‐expressing dendritic cells. Nat Rev Immunol. 2008; 8: 935 – 47.; Sancho D, Joffre OP, Keller AM, Rogers NC, Martinez D, Hernanz‐Falcon P, et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature. 2009; 458: 899 – 903.; Ahrens S, Zelenay S, Sancho D, Hanc P, Kjaer S, Feest C, et al. F‐actin is an evolutionarily conserved damage‐associated molecular pattern recognized by DNGR‐1, a receptor for dead cells. Immunity. 2012; 36: 635 – 45.; van Dinther D, Veninga H, Iborra S, Borg EGF, Hoogterp L, Olesek K, et al. Functional CD169 on macrophages mediates interaction with dendritic cells for CD8(+) T cell cross‐priming. Cell Rep. 2018; 22: 1484 – 95.; Das Mohapatra A, Tirrell I, Bénéchet AP, Pattnayak S, Khanna KM, Srivastava PK. Cross‐dressing of CD8α+ Dendritic Cells with Antigens from Live Mouse Tumor Cells Is a Major Mechanism of Cross‐priming. Cancer Immunology Research. 2020; 8: 10: 1287 – 1299.; Granot T, Senda T, Carpenter DJ, Matsuoka N, Weiner J, Gordon CL, et al. Dendritic cells display subset and tissue‐specific maturation dynamics over human life. Immunity. 2017; 46: 504 – 15.; Calabro S, Liu D, Gallman A, Nascimento MS, Yu Z, Zhang TT, et al. Differential intrasplenic migration of dendritic cell subsets tailors adaptive immunity. Cell Rep. 2016; 16: 2472 – 85.; Nizzoli G, Larghi P, Paroni M, Crosti MC, Moro M, Neddermann P, et al. IL‐10 promotes homeostatic proliferation of human CD8(+) memory T cells and when produced by CD1c(+) DCs, shapes naive CD8(+) T‐cell priming. Eur J Immunol. 2016; 46: 1622 – 32.; Sittig SP, Bakdash G, Weiden J, Skold AE, Tel J, Figdor CG, et al. A comparative study of the T cell stimulatory and polarizing capacity of human primary blood dendritic cell subsets. Mediators Inflamm. 2016; 2016: 3605643.; Bosteels C, Neyt K, Vanheerswynghels M, van Helden MJ, Sichien D, Debeuf N, et al. Inflammatory Type 2 cDCs acquire features of cDC1s and macrophages to orchestrate immunity to respiratory virus infection. Immunity. 2020; 52: 1039 – 56.e9.; Jegalian AG, Facchetti F, Jaffe ES. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol. 2009; 16: 392 – 404.; Brewitz A, Eickhoff S, Dahling S, Quast T, Bedoui S, Kroczek RA, et al. CD8(+) T cells orchestrate pDC‐XCR1(+) dendritic cell spatial and functional cooperativity to optimize priming. Immunity. 2017; 46: 205 – 19.; Fu C, Peng P, Loschko J, Feng L, Pham P, Cui W, et al. Plasmacytoid dendritic cells cross‐prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes. Proc Natl Acad Sci USA. 2020; 117: 23730 – 41.; Igyarto BZ, Jenison MC, Dudda JC, Roers A, Muller W, Koni PA, et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell‐derived IL‐10. J Immunol. 2009; 183: 5085 – 93.; Kissenpfennig A, Henri S, Dubois B, Laplace‐Builhe C, Perrin P, Romani N, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005; 22: 643 – 54.; Sere K, Baek JH, Ober‐Blobaum J, Muller‐Newen G, Tacke F, Yokota Y, et al. Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity. 2012; 37: 905 – 16.; Hammad H, Lambrecht BN, Pochard P, Gosset P, Marquillies P, Tonnel AB, et al. Monocyte‐derived dendritic cells induce a house dust mite‐specific Th2 allergic inflammation in the lung of humanized SCID mice: involvement of CCR7. J Immunol. 2002; 169: 1524 – 34.; Segura E, Touzot M, Bohineust A, Cappuccio A, Chiocchia G, Hosmalin A, et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity. 2013; 38: 336 – 48.; Hase H, Kanno Y, Kojima M, Hasegawa K, Sakurai D, Kojima H, et al. BAFF/BLyS can potentiate B‐cell selection with the B‐cell coreceptor complex. Blood. 2004; 103: 2257 – 65.; Das A, Heesters BA, Bialas A, O’Flynn J, Rifkin IR, Ochando J, et al. Follicular dendritic cell activation by TLR ligands promotes autoreactive B cell responses. Immunity. 2017; 46: 106 – 19.; Heesters BA, Chatterjee P, Kim YA, Gonzalez SF, Kuligowski MP, Kirchhausen T, et al. Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Immunity. 2013; 38: 1164 – 75.; Tew JG, Mandel TE. Prolonged antigen half‐life in the lymphoid follicles of specifically immunized mice. Immunology. 1979; 37: 69 – 76.; Jongbloed SL, Kassianos AJ, McDonald KJ, Clark GJ, Ju X, Angel CE, et al. Human CD141+ (BDCA‐3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross‐presents necrotic cell antigens. J Exp Med. 2010; 207: 1247 – 60.; Ferris ST, Durai V, Wu R, Theisen DJ, Ward JP, Bern MD, et al. cDC1 prime and are licensed by CD4(+) T cells to induce anti‐tumour immunity. Nature. 2020; 584: 624 – 9.; Krishnaswamy JK, Gowthaman U, Zhang B, Mattsson J, Szeponik L, Liu D, et al. Migratory CD11b+ conventional dendritic cells induce T follicular helper cell‐dependent antibody responses. Sci Immunol. 2017; 2: 18: eaam9169. https://doi.org/10.1126/sciimmunol.aam9169Test; Melum GR, Farkas L, Scheel C, Van Dieren B, Gran E, Liu YJ, et al. A thymic stromal lymphopoietin‐responsive dendritic cell subset mediates allergic responses in the upper airway mucosa. J Allergy Clin Immunol. 2014; 134: 613 – 21.e7.; Sanarico N, Ciaramella A, Sacchi A, Bernasconi D, Bossu P, Mariani F, et al. Human monocyte‐derived dendritic cells differentiated in the presence of IL‐2 produce proinflammatory cytokines and prime Th1 immune response. J Leukoc Biol. 2006; 80: 555 – 62.; Qu C, Nguyen VA, Merad M, Randolph GJ. MHC class I/peptide transfer between dendritic cells overcomes poor cross‐presentation by monocyte‐derived APCs that engulf dying cells. J Immunol. 2009; 182: 3650 – 9.; Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco‐Madeira F, Toussaint W, et al. Conventional and monocyte‐derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell‐mediated immunity to house dust mite allergen. Immunity. 2013; 38: 322 – 35.; Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015; 42: 756 – 66.; Bertram KM, Botting RA, Baharlou H, Rhodes JW, Rana H, Graham JD, et al. Identification of HIV transmitting CD11c(+) human epidermal dendritic cells. Nat Commun. 2019; 10: 2759.; Yao C, Zurawski SM, Jarrett ES, Chicoine B, Crabtree J, Peterson EJ, et al. Skin dendritic cells induce follicular helper T cells and protective humoral immune responses. J Allergy Clin Immunol. 2015; 136: 1387 – 97.e1–7.; Klechevsky E, Morita R, Liu M, Cao Y, Coquery S, Thompson‐Snipes L, et al. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity. 2008; 29: 497 – 510.; Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, de Bovis B, et al. CD207+ CD103+ dermal dendritic cells cross‐present keratinocyte‐derived antigens irrespective of the presence of Langerhans cells. J Exp Med. 2010; 207: 189 – 206.; Liu K, Iyoda T, Saternus M, Kimura Y, Inaba K, Steinman RM. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med. 2002; 196: 1091 – 7.; Lutz MB, Backer RA, Clausen BE. Revisiting current concepts on the tolerogenicity of steady‐state dendritic cell subsets and their maturation stages. J Immunol. 2021; 206: 1681 – 9.; Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, et al. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll‐like receptor 9 activation. J Exp Med. 2006; 203: 1999 – 2008.